Sunil J. Wimalawansa, MD, PhD, MBA, DSc.

New Jersey, U.S.A

suniljw@hotmail.com | 908-705-0944

https://www.linkedin.com/in/sunilwimalawansa

__________________________________________________________________________________________

Seeking: Vice President Medical Affair; Vice President Faculty Affairs; Provost
SUMMARY OF LEADERSHIP AND ADMINISTRATIVE EXPERIENCES

Career summary: His qualifications, experience and unique expertise:

Has three terminal degrees; MD, PhD, MBA (executive MBA).
Broader experience in undergraduate, graduate and postgraduate teaching, administration and leadership.
Experience in new drug development, clinical and laboratory management, industry collaborations, costeffective management and forward-thinking decision making, and managing philanthropic organizations.
Experienced as an expert scientific witness in patent litigations, dealing with the media, legislature, and
U.S. Food and Drug Administration (FDA); values added to an organization.
Former Chief of Endocrinology, Metabolism & Nutrition (tenured full-Professor of Medicine over 20 years).
Expertise in laboratory, clinical and translational research; and grants, managing accounts and budgets.
Managed budgets up to $16 million with over 60 employees; designed and delivered projects on time.
Organized and delivered hundreds of medical education and non-CME lecture programs and invited
lectures globally, for academia, scientific and philanthropic organizations, industry, and online teaching.
Retired Air force Squadron Leader. Been a chairperson or a board of directors of several non-profit
foundations and scientific organizations, and has over three decades of experience in philanthropic work.
Successfully completed the National Faculty Education Initiative.
Board of Director Positions:
VasoGenix BioTech (1998-2004)
International Society for Clinical Densitometry (ISCD) (2007-2009)
American Association for Endocrinology (AACE/New Jersey chapter) (2009-2014)
American Association for Endocrinology (AACE/national organization) (2011-2015)
Samadhi Buddhist Foundation (2009-2012)
Turner Syndrome Foundation (2010-Cont.)
Founding President and the Chair of the Board of Directors:
International foundation for Chronic Disabilities (IFCD; http://chronicdisabilities.org)
International Foundation Revitalization, Education, Empowerment & Development (former)
Wimalawansa Foundation (WF; https://wimalawansa.org)
Wimalawansa Education Trust Fund for Disadvantaged Children (WETF)
Foundation for Preventive Health, Environmental Protection, and Research (https://wimalawansa.org/phepro)
Pharmaceutical Industry-related Experience, including Advisory Boards, Consultancy, and Lectureships:
Amgen Pharmaceuticals
Wyeth-Ayerst Pharmaceuticals
AstraZeneca Pharmaceuticals
Eli Lilly Pharmaceuticals
Bayer Pharmaceuticals
Novartis Pharmaceuticals
Apotex, Inc.
Procter and Gamble (NPF)
Teva Pharmaceuticals
Aventis Pharmaceuticals (NPF)
PROFESSIONAL AND ADMINISTRATIVE EXPERIENCE & KEY ACHIEVEMENTS

Associate: Endocrinology, Cardio Metabolic Institute, Veronica Avenue, Somerset, NJ 08873 (Emeritus)
Previous: Professor of Medicine: Professor of Endocrinology, Metabolism & Nutrition, and
University Professor, University of Medicine & Dentistry of New JerseyRobert Wood Johnson
Medical School (UMDNJRWJMS) & the University Hospital20012013
Enhanced clinical and basic scientific research, grants received, and the number of endocrinology
training fellowships and collaborative research programs. During the tenure as the head of the research

program, he also developed service component and process consulting to other research departments,
and developed internal and external productive collaborations for his group and for his colleagues.
Professor of Physiology & Integrative Biology, UMDNJ, Graduate School of Bio-medical Studies
Actively researching and teaching on the postgraduate level; 20022013
Director, Regional Osteoporosis Center20032013; Established a self-funded university-approved
center of excellence with a major grant from the federal government. Center was fully funded and
managed with grants and income it generated. During his tenure, the center he created was considered
as one of the best in the state of New Jersey and attracted additional grant funding.
Chief of Endocrinology, Metabolism and Nutrition, UMDNJ-RWJMS20012008
Significantly improved the efficiency of the clinical operations of the endocrinology division. Doubled
the outpatient encounters and tripled new patient visits; doubled revenue and profits, while cutting
down waiting time for patients by 60%.
In addition to hiring new faculty members, he streamlined the clinics and patients access. Developed a
mathematical model to enhance patient mix to enhance revenue and clinical services.
Founding Director, VasoGenix Pharmaceuticals20012006
With two other scientists, he founded this cardiovascular Biotech Company using a product for which
he holds the patent. Company has ongoing new drug development (IND)-based phase II and III
clinical trials using three of its products. He is also the founder CG-Therapeutics.
Professor, General Medicine & Endocrinology; Director, Osteoporosis Center;
University of Texas, Medical Branch at Galveston, TX.
Director, Biochemical Endocrinology-Osteoporosis Unit; Professor General Internal19942001
Initiated multiple collaborative research programs leading to receiving several state and federal grant
funding. Self-sustaining and self-funded endocrinology research unit and an Osteoporosis Center were
built from scratch buy him using philanthropic fund and by grants from the Texas Higher Education
Coordinating Board and the National Institutes of Health. During his tenure, with his collaborators, he
published averages of six peer-reviewed scientific papers each year, in high-impact journals.
Director, Diabetes Center, Enfield Hospital, North London, United Kingdom19921994
Managed this large diabetes referral center with more than 35,000 clinic visits a year. Significantly
enhanced efficiency of the center by streamlining its operation, including the referral base and cutting
the wait list time from 2 months to 1 week.
Acting Head, Department of Chemical Pathology, Royal Postgraduate Medical School and the Hammersmith
Hospital, London, United Kingdom19901991; successfully managed the department with
approximately 65 employees, with a budget of equivalent of $17.5 million.
Director, Biochemical Endocrinology Unit, Chemical Pathology & Endocrinology, Royal Postgraduate Medical
School, London, United Kingdom19871992
He initiated this research unit funded to him by the British Heart Foundation. His laboratory published,
on average, seven peer-reviewed scientific papers each year in high-impact journals.
KEY EDUCATION STEPS

Executive MBA, Majoring in Leadership & Marketing, The Rutgers University Business School, NJ, 2006
Master of Sociology (MA): Faculty of Arts, University of Peradeniya, Sri Lanka, pending
Doctor of Science (D.Sc.), University of Sri Lanka, 2001
Graduate Certification, diploma in Business in Medicine, Johns Hopkins University, School of Business,
Baltimore, Maryland, 2000
Doctorate in Endocrine Pathology, University of London, United Kingdom, 1987
Fellowship in Endocrinology & Metabolism and Chemical Pathology; Royal Postgraduate Medical School/
Hammersmith Hospital, London, United Kingdom, 1986 (1983-1992)
Diploma course in Aviation Medicine, Royal Air Force, United Kingdom, 1986
Fellowship in Geriatric Medicine & Rehabilitation, Manchester, United Kingdom, 1983
Fellowships in General Internal Medicine, Sri Lanka and in United Kingdom (1977-1983)
Doctor of Medicine, University of Peradeniya, Sri Lanka, 1975

CERTIFICATION AND LICENSURE

United States of America, Full unrestricted Medical License:

New Jersey (active); Pennsylvania, Texas, and Tennessee (inactive)
Full RegistrationGeneral Medical Council, United Kingdom (active)
Full RegistrationSri Lanka Medical Council (active)
Federal Licensing Examination (FLEX), United States of America, 1992
Education Council for Foreign Medical Graduates (ECFMG) Permanent Certification, U.S.A., 1982
GOVERNMENT AND NGO SERVICE

American Association of Clinical Endocrinologists, Board of Directors (2010-2015)

American Association of Clinical EndocrinologistsAACE-N.J. chapter, Board of Directors (2009-2014)
Int. Society Clinical Densitometry, Scientific advisor, and formerly on the Board of Directors (2007-2010)
Former consultant, International Atomic Energy Agency
Board of Directors, Turner Foundation, (from 2010)
Samadhi Foundation of N.J., Board of Directors (2007 to 2013)
Hela Bodhu Padanama, North America & International, FounderPresident (2004-cont.)
International Foundation for Chronic Disabilities (http://chronicdisabilities.org), Founder/President (2006-cont.)
International Foundation for Revitalization, Empowerment, Education & Development, Founder President (1999)
National Aeronautics and Space Administration (NASA), Consultant, Life-Sciences Review Committee
External scientific reviewer for National Institutes of Health (NIH), NASA, and Veteran Administration
Consultant, U.S. Drug Enforcement Administration (DEA)
Chairman/VC, New Jersey Inter Agency Council of Osteoporosis (2005-2009); oversaw more than 250
volunteer programs per year in New Jersey, more than 15,000 volunteer community service hours annually.
ACADEMIC ACTIVITIES

Scientific Publications:
https://wimalawansa.org/publications-by-the-founder
http://www.researchgate.net/profile/Sunil_Wimalawansa/publications
He has published 170 peer-reviewed academic articles, 45 reviews & proceedings, 15 book chapters, and 5 medical
books; has delivered over 200 invited lectures, 50 medicine grand rounds, 285 scientific presentations; multiple
non-medical lectures; and holds 5 medical U.S. and international patents. A regular reviewer for several national
and international scientific journals and has served on editorial boards and in several national and international
scientific review committees (NIH, VA, DEA, and NASA). He holds five U.S. and international medical patents.
PROFESSIONAL AFFILIATIONS

Fellow, American College of Endocrinology, (FACE); Fellow, American College of Physicians, (FACP); American
Medical Association; Master, American College of Diabetes Specialists, (MACDS); member, American Society for
Bone and Mineral Research; International Society for Clinical DensitometryClinical Densitometrist (CCD), a
former member of the board of directors, current scientific advisor; former board of director of AACE, national and
NJ chapter; Certified Research Contract Professional (CRCP); Fellow, Ceylon College of Physicians, (FCCP);
Fellow, International Neuropeptide Society; Member, Royal College of Surgeons (UK), (MRCS); Fellow, Royal
College of Pathologists (UK) (FRCPath); Fellow, Royal College of Physicians (UK), (FRCP).
CURRENT PROJECTS
Educational work: (A) writing a series of medical and philosophy books; (B) teaching endocrinology & nutrition
CME programs, symposia and courses globally, and engaged in web-based teaching; (C) managing an education
foundation and philanthropic work including; (D) establishing novel, cost-effective water purification methods
applicable to all developing countries, (E) broader programs to alleviate chronic kidney disease of unknown
etiology from affected countries; (F) programs design to alleviate malnutrition in pregnant mothers in a infants, (G)
development of a unique, international educational nature center, and (H) job creation, poverty alleviation,
provision of shelter, safe sanitation and clean water, economic development, and womens empowerment in
deprived regions (https://wimalawansa.org).
http://media.aace.com/leadership/aace-members/sunil-j-wimalawansa-md-phd-face-frcpath-fccp-facp-frcp-mba-dsc

BIO SUNIL J. WIMALAWANSA

MD PhD MBA CCD CRCP MACDS FRCPath FACP FACE FCCP FRCP DSc

Professor of Medicine, Endocrinology & Nutrition

Dr. Wimalawansa is a clinician-scientist, a faculty member/medical educator, an expert in endocrinology,
osteoporosis and metabolic bone disease, vitamin D, and nutrition. He holds numerous distinctions as an
educator, author, inventor, researcher, innovator, executive board member, administrator, and philanthropist.
In 2000, he completed a diploma in medical administration at the Johns Hopkins University School of
Business, and in 2006, he earned an Executive Master of Business Administration degree from Rutgers
University.
Former university professor, professor of medicine and chief of the Division of Endocrinology, Metabolism and
Nutrition, and the director of the regional osteoporosis center, at the Robert Wood Johnson Medical School and
Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He has also served as a professor of
physiology and integrative biology and pharmacology, Graduate School of Biomedical Sciences at the University
of Medicine and Dentistry, New Brunswick, New Jersey.
He authored several books on subjects including medicine, chronic kidney disease, nutrition, history, and
meditation. He received multiple awards, including young investigator awards from several professional
societies, The Dr. Boy Frame Award for Clinical Excellence in Metabolic Bone Diseases (1993), American
Endocrine Society Glen Foundation Awards, and an innovation award from the Asian Chamber of Commerce
(2000). In 2005, he received a coveted Lifetime Achievement Award from the Sri Lanka Foundation, Los
Angeles, California, for his contributions to science, humanity, and society. The International Society for
Clinical Densitometry awarded him the 2007 Dr. Oscar Gluck Humanitarian Award.
He is a retired Air Force squadron leader, the Founding President of several nonprofit organizations, including
the International Foundation for Chronic Disabilities (ChronicDisabilities.org); the International Foundation
for Revitalization, Empowerment, Education and Development; Hela Bodu [Empowerment] Foundation;
Wimalawansa Foundation; the Wimalawansa Education Trust Fund for Needy Children, and an Organization
Promoting Health and Protecting Environment (PHEPRO). He is one of the 3 founders of the VasoGenix
biotech. He has been a board of directors of the American Association of Clinical Endocrinology (national and
New Jersey state chapter), International Society of Clinical Densitometry, Turner Foundation and Samadhi
Foundation, and a chair or a member of several national and international scientific committees.
His laboratory and clinical research focused on pharmaceuticals, peptides, peptide receptors, and metabolic
bone diseases were funded primarily by the NIH. He has made several seminal contributions to medicine,
medical research, and pharmaceuticals. These include development of novel modes of treating osteoporosis
including nitroglycerine, once-a-week bisphosphonates therapy, combination therapies, a technique to
enhance the efficacy of bisphosphonates, and cost-effective therapies such as vitamin E and nitric oxide donor
treatment regimens. In 1984, he was the first to develop and demonstrate the value of intra-operative
hormone assays using measurements of calcitonin and parathyroid hormones as examples to assist endocrine
surgical procedures, which is now used worldwide as a standard of practice, helping thousands of endocrine
surgeons and patients. He also developed a highly cost-effective water purification method, applicable
worldwide, to provide clean potable water to needy populations.
He has served on several national and international scientific review committees, including the NIH, VA, DEA,
and NASA. In addition to publishing 170 peer-reviewed articles, 45 reviews and proceedings, 15 book chapters,
8 books, and holding 5 medical patents, he has delivered over 190 national and international invited lectures,
over 350 scientific presentations worldwide, and numerous non-medical lectures. He is a regular reviewer for
several national & international scientific journals and serve on several editorial boards.
FOR WHOS WHO PROFESSIONAL OF THE YEAR LINK PLEASE CLICK HERE

LINKEDIN PROFILE HERE ; RESUME HERE ; PUBLICATIONS PLEASE CLICK HERE